Veteran fundraising and investor relations executive will lead March Capital’s Capital Formation efforts
March Capital, a leading enterprise venture growth firm based in Santa Monica, California, today announced the appointment of Oliver Marques as Partner, Capital Formation. Working directly with the firm’s Managing Partners, Mr. Marques will leverage his significant capital raising expertise to deepen and expand March Capital’s partnerships with leading sovereign wealth funds, registered investment advisors, endowments, and single/multifamily offices.
Mr. Marques joins March Capital with over a decade of experience in investment management and capital raising across global markets. Previously, he served as Head of Intermediary & Institutional Distribution at PineBridge Investments, a private, multi-billion-dollar global asset manager based in the United Kingdom. During his tenure, Mr. Marques represented both public and private funds across the United Kingdom, the United States, and the Middle East, and successfully raised capital across the full spectrum of both wealth and institutional investors.
“As we enter 2025, we are seeing significant optimism and excitement around the potential for growth and innovation in the technology sector, creating immense opportunity for a resurgence in capital raising and investment,” said Jamie Montgomery, March Capital Co-Founder and Managing Partner. “We are therefore thrilled to add Oliver to the March Capital leadership team as we advance our capital raising strategy and strengthen our relationships with both new and existing investors. We are confident that Oliver’s extensive experience and proven track record in capital formation will enhance our world-class technology investment platform as we finance and grow the next generation of entrepreneurs and startups driving the Innovation Economy forward.”
With $1.65B+ in AUM over 4 funds and across 25+ market-leading technology companies, March Capital is well-positioned to continue supporting new and existing investors and is focused on making venture and early growth investments in innovative, fast-growing companies in the cloud software, cybersecurity, and cloud/data infrastructure sectors.
The firm’s disciplined and hands-on investment approach has led to top-quartile investor returns.
An HEC Paris-DowJones Study, published in 2023, ranked March Capital 7th globally in aggregate performance among 415 venture capital and venture growth firms for funds raised between 2009 to 2018.
“I am thrilled to join the talented team at March Capital, a highly respected venture investor and trusted partner to many of the fastest growing and most innovative enterprise software companies,” said Oliver Marques, Partner at March Capital. “I look forward to building on the success of March’s impressive fundraising efforts and creating an industry leading Capital Formation Team focused on providing excellent service and unique solutions to our expansive and growing investor base.”
Mr. Marques previously held roles at Hermes Investment Management (Now Federated Hermes) and ATI Investments (now Alliance Witan). Oliver graduated from the University of St. Andrews and holds a Certificate in Investment Management (Unit 1 & 2) from CFA UK.
About March Capital
March Capital is a top-tier venture growth firm headquartered in Santa Monica, California and has been investing globally since 2014. March is committed to partnering with exceptional entrepreneurs to build great technology companies and to scale them globally. With $1.65B+ in capital over 4 funds and across 25+ market-leading technology companies, March accelerates the digital transformation of enterprise applications, cloud & data infrastructure, vertical software, and scientific discovery. Our vision is to create a best-in-class technology investment platform by combining intense sector focus, patience, access to a global leadership network (including founding The Montgomery Summit), and high-impact portfolio engagement to inspire and to accelerate extraordinary AI-native companies like CrowdStrike, Essential AI, Forter, Generate:Biomedicines, Nile, and Uniphore. For more information, please visit www.marchcp.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250123857844/en/
